RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCOPUS SCIE

    Nevirapine nanosuspensions: stability, plasma compatibility and sterilization

    한글로보기

    https://www.riss.kr/link?id=A105019012

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    The feasibility of preparing lyophilized or spray dried forms for reconstitution into nanosuspension (NS) was investigated in this study. The bare and surface modified aqueous NS of nevirapine were successfully converted into an anhydrous form by both techniques. The optimization of suitable cryoprotectant is essential to obtain completely dry product of desired properties. The NS adsorbed spray dried powder and granules would serve as excellent carriers for oral antiretroviral delivery. Furthermore,granules compressed to tablet showed sustained release compared to conventional marketed tablet. These results indicated that NS can be lyophilized and spray dried to prepare a product suitable for a parenteral and oral dosage form, respectively provided the formulation composition withstand phase changes during the drying processes process. Effect of sterilization method viz. steam and radiation on aqueous and lyophilized NS was also studied.
    번역하기

    The feasibility of preparing lyophilized or spray dried forms for reconstitution into nanosuspension (NS) was investigated in this study. The bare and surface modified aqueous NS of nevirapine were successfully converted into an anhydrous form by both...

    The feasibility of preparing lyophilized or spray dried forms for reconstitution into nanosuspension (NS) was investigated in this study. The bare and surface modified aqueous NS of nevirapine were successfully converted into an anhydrous form by both techniques. The optimization of suitable cryoprotectant is essential to obtain completely dry product of desired properties. The NS adsorbed spray dried powder and granules would serve as excellent carriers for oral antiretroviral delivery. Furthermore,granules compressed to tablet showed sustained release compared to conventional marketed tablet. These results indicated that NS can be lyophilized and spray dried to prepare a product suitable for a parenteral and oral dosage form, respectively provided the formulation composition withstand phase changes during the drying processes process. Effect of sterilization method viz. steam and radiation on aqueous and lyophilized NS was also studied.

    더보기

    참고문헌 (Reference)

    1 Knight SC, "Storage of humanlymphocytes by freezing in serum alone" 14 (14): 112-115, 1977

    2 Schiffter H, "Spray-freeze-drying ofnanosuspensions: the manufacture of insulin particles for needlefreeballistic powder delivery" 7 : 483-500, 2010

    3 Hubalek Z, "Protectants used in the cryopreservation ofmicroorganisms" 46 (46): 205-229, 2003

    4 Al Shaal L, "Production andcharacterization of antioxidant apigenin nanocrystals as a novelUV skin protective formulation" 420 (420): 133-140, 2011

    5 Gianfrancesco A, "Powder agglomerationduring the spray-drying process: measurements of airproperties" 88 (88): 53-64, 2008

    6 Na GC, "Physicalstability of ethyl diatrizoate nanocrystalline suspension in steamsterilization" 16 (16): 569-574, 1999

    7 Nash RA, "Parenteral suspensions" 26 (26): 91-94, 1972

    8 Mu¨ller RH, "Nanosuspensions—aformulation approach for poorly soluble and poorly bioavailabledrugs, In Handbook of pharmaceutical controlledrelease" Marcel Dekker 345-357, 2000

    9 Shegokar R, "Nanocrystals: industrially feasiblemultifunctional formulation technology for poorly solubleactives" 399 (399): 129-139, 2010

    10 Mitri K, "Luteinnanocrystals as antioxidant formulation for oral and dermaldelivery" 420 (420): 141-146, 2011

    1 Knight SC, "Storage of humanlymphocytes by freezing in serum alone" 14 (14): 112-115, 1977

    2 Schiffter H, "Spray-freeze-drying ofnanosuspensions: the manufacture of insulin particles for needlefreeballistic powder delivery" 7 : 483-500, 2010

    3 Hubalek Z, "Protectants used in the cryopreservation ofmicroorganisms" 46 (46): 205-229, 2003

    4 Al Shaal L, "Production andcharacterization of antioxidant apigenin nanocrystals as a novelUV skin protective formulation" 420 (420): 133-140, 2011

    5 Gianfrancesco A, "Powder agglomerationduring the spray-drying process: measurements of airproperties" 88 (88): 53-64, 2008

    6 Na GC, "Physicalstability of ethyl diatrizoate nanocrystalline suspension in steamsterilization" 16 (16): 569-574, 1999

    7 Nash RA, "Parenteral suspensions" 26 (26): 91-94, 1972

    8 Mu¨ller RH, "Nanosuspensions—aformulation approach for poorly soluble and poorly bioavailabledrugs, In Handbook of pharmaceutical controlledrelease" Marcel Dekker 345-357, 2000

    9 Shegokar R, "Nanocrystals: industrially feasiblemultifunctional formulation technology for poorly solubleactives" 399 (399): 129-139, 2010

    10 Mitri K, "Luteinnanocrystals as antioxidant formulation for oral and dermaldelivery" 420 (420): 141-146, 2011

    11 Stark B, "Long-term stability of stericallystabilized liposomes by freezing and freeze-drying: effects ofcryoprotectants on structure" 41 (41): 546-555, 2010

    12 Ambrus R, "Investigation of preparation parameters to improve thedissolution of poorly water-soluble meloxicam" 381 (381): 153-159, 2009

    13 Nounou MM, "Influence of different sugarcryoprotectants on the stability and physio-chemical characteristicsof freeze dried 5-fluorouracil plurilamillar vesicles" 13 (13): 2005

    14 Aramwit P, "In vitro plasma compatibilitystudy of a nanosuspension formulation" 60 (60): 211-217, 2006

    15 Manju S, "Gold nanoparticles generated andstabilized by water soluble curcumin-polymer conjugate: bloodcompatibility evaluation and targeted drug delivery onto cancercells" 368 (368): 144-151, 2012

    16 Beirowski J, "Freezedryingof nanosuspensions, part 3: investigation of factorscompromising storage stability of highly concentrated drugnanosuspensions" 101 (101): 354-362, 2012

    17 Beirowski J, "Freezedryingof nanosuspensions, 1: freezing rate versus formulationdesign as critical factors to preserve the original particle sizedistribution" 100 (100): 1958-1968, 2011

    18 Beirowski J, "Freezedrying of nanosuspensions, 2: the role of the critical formulationtemperature on stability of drug nanosuspensions and its practicalimplication on process design" 2011

    19 Dusanter A, "Formulation of highlyconcentrated suspensions for spray drying in a fluidized bed" 26 : 2008

    20 Dave R, "Effect of cryoprotectanton lyophilisation of doxorubicin—HCl loaded chitosan nanoparticles" 3 (3): 1769-1772, 2012

    21 Chaubal MV, "Conversion of nanosuspensions intodry powders by spray drying: a case study" 25 (25): 2302-2308, 2008

    22 Koziara JM, "Bloodcompatibility of cetyl alcohol/polysorbate-based nanoparticles" 22 (22): 1821-1828, 2005

    23 Kayaert P, "Bead layering as aprocess to stabilize nanosuspensions: influence of drug hydrophobicityon nanocrystal reagglomeration following in vitrorelease from sugar beads" 63 : 1446-1453, 2011

    24 Jain S, "A two-stage strategy for sterilization ofpoly(lactide-co-glycolide) particles by gamma-irradiation doesnot impair their potency for vaccine delivery" 100 (100): 646-654, 2011

    더보기

    동일학술지(권/호) 다른 논문

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2020-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2010-06-09 학술지명변경 한글명 : 약제학회지 -> Journal of Pharmaceutical Investigation
    외국어명 : Jorunal of Korean Pharmaceutical Sciences -> Journal of Pharmaceutical Investigation
    KCI등재
    2010-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2008-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2006-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2005-06-16 학회명변경 영문명 : The Korean Society Of Pharmaceutics -> The Korean Society of Pharmaceutical Sciences and Technology KCI등재
    2004-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2001-07-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    1999-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.18 0.18 0.14
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.13 0.11 0.374 0.02
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼